314 Results (Page 12 of 13)
Australia Markets Research Reports
Australia ECG Equipments Market Analysis
The Australia ECG Equipment Market is expected to witness growth from $107 Mn in 2022 to $210 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. The Australian government has recently increased healthcare spending, which is likely to fuel market expansion for ECG equipment. The market is segmented by product type and by the end user. Some key players in this market include Tomlin Medical, Anatomics, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
Australia Women's Health Market Analysis
Australia women’s health market is projected to grow from $479 Mn in 2022 to $781 Mn by 2030, registering a CAGR of 6.30% during the forecast period of 2022-30. The Australian government has implemented a number of policies and programs aimed at promoting women's health, such as providing funding for cancer screenings and research on women's health issues through the Medicare Benefits Schedule (MBS). Companies such as Pfizer, AstraZeneca, and GlaxoSmithKline are major players in the Australia women's health market, producing drugs and supplements for conditions such as osteoporosis and menopause.
Australia 3D Printing Medical Devices Market Analysis
Australia's 3D printing medical devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Stryker, and others.
Australia Depression Therapeutics Market Analysis
The Australian depression therapeutics market is expected to witness growth from $121 Mn in 2022 to $204 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The development of newer and innovative therapeutics by Australian pharmaceutical companies and the increased demand for personalized depression treatment in Australia are driving the growth of the market. The Australian depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Kira Biotech, Zucero Therapeutics, and Pfizer are the major players in the Australian depression therapeutics market.
Australia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Australia liver cancer therapeutics market will reach a value of $142.3 Mn from $35.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. Liver cancer therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Imugene Limited, Kazia Therapeutics, and Sirtex Medical Limited. Liver cancer therapeutics in Australia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Australia Cardiac Surgery Instruments Market Analysis
The Australian Cardiac Surgery Instruments Market is expected to witness growth from $25 Mn in 2022 to $46 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Australia, the demand for minimally invasive surgical instruments, like endoscopes and laparoscopic instruments, is anticipated to increase in the Australian healthcare market as patients there seek out less invasive surgical choices that reduce scarring and recovery time. The market is segmented by type, application and by end user. Some key players in this market include Fairmont Medical Products, Rowe Medical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Australia Healthcare Claims Management Market Analysis
The Australian healthcare claims management market is projected to grow from $320.4 Mn in 2022 to $1897.54 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in healthcare provider consolidation, technological advancements, regulatory changes and an increase in healthcare spending. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Proclaim, Medibank, Riskware, Cognizant and Accenture.
Australia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Australia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Liver Disease Therapeutics market will reach a value of $483 Mn from $277 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare Australia, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Australia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Australian Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Australia Oncology Clinical Trials Market Analysis
Australia's oncology clinical trials market is projected to grow from $151.8 Mn in 2022 to $260.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the rising investment in clinical research, increased patient education and engagement, and the development of new and innovative clinical trial designs. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, AstraZeneca plc & Kazia Therapeutics Limited.
Australia Diabetes Drugs Market Analysis
The Australia diabetes drugs market size was valued at $0.74 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030 and will reach $1.33 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Australia diabetes drug market will grow because of the high prevalence of diabetes in the country, which creates a significant demand for medications to manage the disease. The key market players are CSL Limited, AstraZeneca, Novo Nordisk, Sanofi, and others.
Australia Alexipharmic Drugs Market Analysis
Australia's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The rising incidence of poisonings due to accidental or intentional exposure to toxins is driving the demand for alexipharmic drugs in Australia. The key market players are CSL Behring, Hospira, Mylan, Phebra (AUS), and others.
Australia Neurology Clinical Trials Market Analysis
The Australia Neurology Clinical Trials market is projected to grow from $62.8 Mn in 2022 to $107.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by internationally competitive government subsidies for R&D investment and a well-developed infrastructure to support clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc, Neuroscience Trials Australia & Prana Biotechnology Limited.
Australia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Australia infectious disease therapeutics market will reach a value of $2.27 Bn from $1.44 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. Infectious Disease Therapeutics in Australia is dominated by domestic pharmaceutical companies such as AdAlta, Starpharma and CSL. The Infectious Disease Therapeutics market in Australia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Australia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Australia.
Australia Clinical Diagnostics Market Analysis
Australia's clinical diagnostic market was valued at $827 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022 to 2030 and will reach $1475 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Australian Clinical Labs, Healthscope Limited, Primary Health Care Limited, Sonic Healthcare, Healius, Austech Medical Laboratories, I-Med Radiology Network, and others.
Australia Artificial Intelligence (AI) in Diagnostics Market Analysis
The Australia Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.01 Bn in 2022 to $0.14 Bn by 2030, registering a CAGR 36.5% during the forecast period of 2022 - 2030. The market will be driven by collaborations among businesses, academia, and healthcare providers and a rise in demand for precise diagnostics. The market is segmented by component & by diagnosis. Some of the major players include Siemens Healthineers, Philips Healthcare & Harrison.
Australia Rheumatology Drugs Market Analysis
The Australia Rheumatology Drugs Market is projected to grow from $0.733 Bn in 2022 to $1.026 Bn by 2030, registering a CAGR of 4.30% during the forecast period of 2022–2030. The Australian government plays a key role in the rheumatology drugs market through its reimbursement policies and the Pharmaceutical Benefits Scheme (PBS), which provides public funding for a range of prescription drugs, including those used to treat rheumatic diseases. In terms of market players, the Australian rheumatology drugs market is dominated by large multinational pharmaceutical companies, such as Pfizer Inc., Merck & Co., Inc., and AbbVie Inc., among others.
Australia Orphan Diseases Drugs Market Analysis
The Australia Orphan Diseases Drugs Market is projected to grow from $1.858 Bn in 2022 to $4.534 Bn by 2030, registering a CAGR of 11.80% during the forecast period of 2022 - 2030. It is growing, due to the increasing prevalence of rare diseases and the development of new treatments. Some key players in the Australia orphan diseases drugs market are Pfizer, Sanofi, Novartis, and Roche.
Australia HIV Therapeutics Market Analysis
By 2030, it is anticipated that the Australia HIV therapeutics market will reach a value of $229.48 Mn from $165.12 Mn in 2022, growing at a CAGR of 4.2% during 2022-2030. The market is primarily dominated by local players such as Bionomics, Prima Biomed and Imugene Limited. The market is driven by innovation in research and development, increasing prevalence, and government funding policies. The HIV therapeutics market in Australia is segmented by type, product, and geography, end user, and distribution channel.
Australia Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Australia dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. The dermatology drug market in Australia is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Australia Bioinformatics Market Analysis
The Australia Bioinformatics market is projected to grow from $184.2 Mn in 2022 to $683 Mn by 2030, registering a CAGR of 17.80% during the forecast period of 2022 - 2030. The main factors driving the growth would be its location, government support, and leading research organizations. The market is segmented by technology and by application. Some of the major players include Bioplatforms Australia (AUS), Agilent Technologies, Illumina Inc., IBM Life Sciences, and Thermo Fisher Scientific.
Australia Lung Cancer Drugs Market Analysis
The Australia Lung Cancer Drug Market is projected to grow from $115 Mn in 2022 to $242 Mn by 2030, registering a CAGR of 9.80% during the forecast period of 2022 – 2030. The incidence of lung cancer in Australia has been increasing in recent years, due in part to the high rates of smoking in the country. Some of the key players in the lung cancer drug market in Australia include AstraZeneca, Roche, Merck, Pfizer, and Bristol-Myers Squibb.
Australia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Australia oncology drugs market will reach a value of $6.3 Bn from $2.36 Bn in 2022, growing at a CAGR of 13.1% during 2022-2030. The companies operating in the oncology drug in Australia market are Bristol Myers Squibb, Aucentra Therapeutics, and Natco Pharma. The Australia oncology drugs market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments and taxation policies by the government are some of the major drivers of growth in the Australian oncology drug market.
Australia Digital Therapeutics Market Analysis
This report presents a strategic analysis of the Australia Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Digital Therapeutics Market, offering unmatched value, accuracy and expert insights.
Australia eHealth Market Analysis
This report presents a strategic analysis of the Australia eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia eHealth Market, offering unmatched value, accuracy and expert insights.
